Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies
Ken-ichi Miyamoto1, Sakiko Haito-Sugino, Shoji Kuwahara
1Department of Molecular Nutrition, Institute of Health Biosciences, University of Tokushima Graduate School Tokushima 770-8503, Japan. miyamoto@nutr.med.tokushima-u.ac.jp
Journal of Pharmaceutical Sciences
|May 14, 2011
Summary
Inorganic phosphate (Pi) regulation is crucial for health. Inhibiting sodium-dependent Pi transporters offers a promising strategy for managing phosphate levels in chronic kidney disease patients.
Area of Science:
- Nephrology
- Physiology
- Molecular Biology
Background:
- Inorganic phosphate (Pi) is vital, but imbalances cause severe health issues like ectopic calcification and cardiovascular disease.
- Hyperphosphatemia is common in chronic kidney disease (CKD) and linked to higher mortality.
- Current treatments (diet, dialysis, binders) struggle with efficient phosphate control.
Purpose of the Study:
- To review the roles of sodium-dependent Pi (NaPi) transporters in maintaining Pi homeostasis.
- To explore NaPi transporter inhibition as a therapeutic target for CKD patients.
Main Methods:
- Literature review of NaPi transporter functions.
- Discussion of knockout mouse models for NaPi transporters (types I-III).
Main Results:
- Identified three main types of NaPi transporters: SLC17A1 (NaPi-I), SLC34 (NaPi-IIa, IIb, IIc), and SLC20 (PiT1, PiT2).
- Highlighted the critical role of NaPi transporters in regulating serum Pi levels.
Conclusions:
- NaPi transporters are key regulators of phosphate homeostasis.
- Targeting NaPi transporters presents a potential therapeutic avenue for managing hyperphosphatemia in CKD.
More Related Videos
10:08Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
07:38Functional Characterization of Na+/H+ Exchangers of Intracellular Compartments Using Proton-killing Selection to Express Them at the Plasma Membrane
Published on: March 30, 2015
Related Concept Videos
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:44The Significance of Membrane Transport
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
01:27ATP Driven Pumps I: An Overview
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and are...
01:31ABC Transporters: Exporter
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
01:14Active Transport
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
01:31Membrane Transporters
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...